1. Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for multiple myeloma: final results of the LYRA study. Issue 10 (24th August 2022) Authors: Yimer, Habte; Melear, Jason; Faber, Edward; Bensinger, William I.; Burke, John M.; Narang, Mohit; Stevens, Don; Gray, Kathleen S.; Lutska, Yana; Bobba, Padma; Qi, Keqin; Hoehn, Daniela; Qi, Ming; Lin, Thomas S.; Rifkin, Robert M. Journal: Leukemia & lymphoma Issue: Volume 63:Issue 10(2022) Page Start: 2383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗